http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2597366-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6bf4951b2751678fe1c862fee6446dd
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
filingDate 2015-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77b4a0d95d5206f000fff64054a7c971
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_945ed8c9444dc82403a2b454c3220e0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_200b949961df4c21666e0579f7f2bc9f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a328f627610b8355dca271b43be09427
publicationDate 2016-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2597366-C1
titleOfInvention Method of determining whether to perform procedure of occluder closing of open oval window of interatrial septum in patients suffering from migraine
abstract FIELD: medicine. n SUBSTANCE: invention relates to cardiology and neurology. Method comprises performing ultrasound inspection of heart, including contrast echocardiography (C-EchoCG) with contrasting of right cardiac chambers. When performing C-EchoCG, method includes further alternating provocative functional stress tests, which are discontinued upon detecting valley penetration of portion contrast micro-bubbles from right atrium into systemic circulation. Method also incudes two-dimensional ultrasound inspection of central veins and determining practicability of performing procedure for occluder closing of open oval window of interatrial septum by patient with migraine, in which in during ech contrast, valley penetration of portion contrast micro-bubbles from right atrium into systemic circulation is detected, and during two-dimensional ultrasound inspection of central veins, spontaneous echo contrasting is detected in one of them. n EFFECT: method increases efficiency of determining expediency of closing open oval window and thereby improving effects of treatment of patients. n 1 cl, 6 ex
priorityDate 2015-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8BW75
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534940
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743280
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP56560
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21398
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4510
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21397
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493276
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21396
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO18851
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49253
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ64133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506650
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP46882
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27338
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3151
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555446
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6NSN2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ556K4
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534242
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743214
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ556K3
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408264951
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID522325
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19643
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ54IT3

Total number of triples: 41.